112 related articles for article (PubMed ID: 2851858)
1. Molecular mechanisms in the action of minaprine.
Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):629-37. PubMed ID: 2851858
[TBL] [Abstract][Full Text] [Related]
2. Effects of repeated trazodone administrations on serotonergic neurotransmission: biochemical studies.
Gandolfi O; Roncada P; Dall'Olio R
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):941-52. PubMed ID: 2554363
[TBL] [Abstract][Full Text] [Related]
3. Biochemical effects of minaprine on striatal dopaminergic neurons in rats.
Ferretti P; Algeri S; Benfenati F; Cimino M; Ferretti C; Garattini S; Lipartiti M
J Pharm Pharmacol; 1984 Jan; 36(1):48-50. PubMed ID: 6141265
[TBL] [Abstract][Full Text] [Related]
4. Daily bupropion injections for 3 weeks attenuate the NE stimulation of adenylate cyclase and the number of beta-adrenergic recognition sites in rat frontal cortex.
Gandolfi O; Barbaccia ML; Chuang DM; Costa E
Neuropharmacology; 1983 Jul; 22(7):927-9. PubMed ID: 6312356
[TBL] [Abstract][Full Text] [Related]
5. The (-)-deprenyl actions on beta-adrenergic receptors require the integrity of brain serotonergic axon terminals.
Gandolfi O; Barbaccia ML; Costa E
Eur J Pharmacol; 1984 Apr; 100(2):233-7. PubMed ID: 6329776
[TBL] [Abstract][Full Text] [Related]
6. Minaprine, a new drug with antidepressant properties.
Bizière K; Worms P; Kan JP; Mandel P; Garattini S; Roncucci R
Drugs Exp Clin Res; 1985; 11(12):831-40. PubMed ID: 3836113
[TBL] [Abstract][Full Text] [Related]
7. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
Ferris RM; Beaman OJ
Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
[TBL] [Abstract][Full Text] [Related]
8. (-)-Deprenyl a selective MAO "B' inhibitor, increases [3H]imipramine binding and decreases beta-adrenergic receptor function.
Zsilla G; Barbaccia ML; Gandolfi O; Knoll J; Costa E
Eur J Pharmacol; 1983 Apr; 89(1-2):111-7. PubMed ID: 6305680
[TBL] [Abstract][Full Text] [Related]
9. 5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices.
Muramatsu M; Tamaki-Ohashi J; Usuki C; Araki H; Chaki S; Aihara H
Eur J Pharmacol; 1988 Aug; 153(1):89-95. PubMed ID: 2975224
[TBL] [Abstract][Full Text] [Related]
10. Serotonin-2 receptor-mediated regulation of release of acetylcholine by minaprine in cholinergic nerve terminal of hippocampus of rat.
Muramatsu M; Tamaki-Ohashi J; Usuki C; Araki H; Aihara H
Neuropharmacology; 1988 Jun; 27(6):603-9. PubMed ID: 3419543
[TBL] [Abstract][Full Text] [Related]
11. Effect of the antidepressant minaprine on both forms of monoamine oxidase in the rat.
Kan JP; Mouget-Goniot C; Worms P; Biziere K
Biochem Pharmacol; 1986 Mar; 35(6):973-8. PubMed ID: 3954800
[TBL] [Abstract][Full Text] [Related]
12. Post-training minaprine enhances memory storage in mice: involvement of D1 and D2 dopamine receptors.
Puglisi-Allegra S; Cabib S; Cestari V; Castellano C
Psychopharmacology (Berl); 1994 Jan; 113(3-4):476-80. PubMed ID: 7862862
[TBL] [Abstract][Full Text] [Related]
13. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
14. Effect of 3-(2-morpholinoethylamino)-4-methyl-6-phenyl pyridazine dihydrochloride (minaprine) on plasma cortisone levels of physostigmine treated rats.
Laborit H; Bonifacj JF
Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):63-7. PubMed ID: 6729250
[TBL] [Abstract][Full Text] [Related]
15. Alterations of serotonin neurotransmission and inhibition of mouse-killing behavior: III. Effects of minaprine, CM 30366 and SR 95191.
Isel F; Mandel P
Pharmacol Biochem Behav; 1989 Jul; 33(3):655-62. PubMed ID: 2531423
[TBL] [Abstract][Full Text] [Related]
16. Effects of subchronic minaprine on dopamine release in the ventral striatum and on immobility in the forced swimming test.
Imperato A; Obinu MC; Cabib S; Cestari V; Puglisi-Allegra S
Neurosci Lett; 1994 Jan; 166(1):69-72. PubMed ID: 8190361
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of minaprine on the cerebrum of rodents.
Okuyama S; Karasawa Y; Shiratsuchi A; Araki H; Aihara H
Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):381-95. PubMed ID: 3175336
[TBL] [Abstract][Full Text] [Related]
18. Increased low-affinity 3H-spiroperidol binding to rat cortical membranes after chronic antidepressant treatments.
Antkiewicz-Michaluk L; Rokosz-Pelc A; Vetulani J
Pol J Pharmacol Pharm; 1985; 37(3):317-23. PubMed ID: 4070080
[TBL] [Abstract][Full Text] [Related]
19. Chronic antidepressant treatment and mouse brain 3H-imipramine binding.
Severson JA; Anderson B
J Neurosci Res; 1986; 16(2):429-38. PubMed ID: 3020258
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of the active site of minaprine from that of phencyclidine in rat hippocampus.
Chaki S; Usuki-Ito C; Muramatsu M; Otomo S
Res Commun Chem Pathol Pharmacol; 1990 Jul; 69(1):85-98. PubMed ID: 1977191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
